Literature DB >> 27142043

Carbapenem-resistant Lactobacillus intra-abdominal infection in a renal transplant recipient with a history of probiotic consumption.

Jakapat Vanichanan1, Violeta Chávez2, Audrey Wanger2, Aleksandra M De Golovine3, Karen J Vigil4.   

Abstract

BACKGROUND: Lactobacillus sp. is a low virulence bacterium, which rarely causes infection in immunocompetent individuals and usually is considered a contaminant. Normally this organism is susceptible to β-lactam antibiotics, yet resistant strains have been reported. CASE PRESENTATION AND DISCUSSION: Here, we report a case of a 60-year-old renal transplant recipient who developed an intra-abdominal abscess which grew a carbapenem-resistant Lactobacillus casei. This is significant since it is the first report of a clinical isolate of Lactobacillus sp. that demonstrated both microbiological and clinical resistance to carbapenem use. Moreover, the probiotic supplement that the patient had taken also grew a similar organism raising the concern of probiotic associated infection in immunocompromised individual.

Entities:  

Keywords:  Carbapenem; Drug resistant; Intra-abdominal infection; Lactobacillus; Probiotic; Renal transplant

Mesh:

Substances:

Year:  2016        PMID: 27142043     DOI: 10.1007/s15010-016-0903-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

Review 1.  Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis.

Authors:  S J Antony; C W Stratton; J S Dummer
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

2.  Catheter-related bacteremia due to Lactobacillus rhamnosus in a single-lung transplant recipient.

Authors:  E Carretto; D Barbarini; F C Marzani; P Fumagalli; V Monzillo; P Marone; V Emmi
Journal:  Scand J Infect Dis       Date:  2001

3.  Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Frédéric Robin; Catherine Paillard; Hélène Marchandin; François Demeocq; Richard Bonnet; Claire Hennequin
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

4.  Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

Authors:  Nada Rayes; Daniel Seehofer; Tom Theruvath; Reinhold A Schiller; Jan M Langrehr; Sven Jonas; Stig Bengmark; Peter Neuhaus
Journal:  Am J Transplant       Date:  2005-01       Impact factor: 8.086

5.  Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 6.  Probiotics and the gut microbiota in intestinal health and disease.

Authors:  Mélanie G Gareau; Philip M Sherman; W Allan Walker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-27       Impact factor: 46.802

7.  Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis.

Authors:  Elaheh Vahabnezhad; Albert Brian Mochon; Laura Joyce Wozniak; David Alexander Ziring
Journal:  J Clin Gastroenterol       Date:  2013 May-Jun       Impact factor: 3.062

8.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Marc Gh Besselink; Hjalmar C van Santvoort; Erik Buskens; Marja A Boermeester; Harry van Goor; Harro M Timmerman; Vincent B Nieuwenhuijs; Thomas L Bollen; Bert van Ramshorst; Ben Jm Witteman; Camiel Rosman; Rutger J Ploeg; Menno A Brink; Alexander Fm Schaapherder; Cornelis Hc Dejong; Peter J Wahab; Cees Jhm van Laarhoven; Erwin van der Harst; Casper Hj van Eijck; Miguel A Cuesta; Louis Ma Akkermans; Hein G Gooszen
Journal:  Lancet       Date:  2008-02-14       Impact factor: 79.321

9.  In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates.

Authors:  P R Murray; A C Niles
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Jan-Feb       Impact factor: 2.803

10.  Transmission of Lactobacillus pneumonia by a transplanted lung.

Authors:  S D Jones; D A Fullerton; M R Zamora; D B Badesch; D N Campbell; F L Grover
Journal:  Ann Thorac Surg       Date:  1994-09       Impact factor: 4.330

View more
  4 in total

Review 1.  What Is Wrong with Enterococcal Probiotics?

Authors:  Alexander Suvorov
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

Review 2.  Bacterial, Gut Microbiome-Modifying Therapies to Defend against Multidrug Resistant Organisms.

Authors:  Amy Feehan; Julia Garcia-Diaz
Journal:  Microorganisms       Date:  2020-01-24

3.  Lactobacillus rhamnosus Bacteremia in an Immunocompromised Renal Transplant Patient.

Authors:  Selin Sendil; Isha Shrimanker; Qurat Mansoora; John Goldman; Vinod K Nookala
Journal:  Cureus       Date:  2020-02-05

Review 4.  Probiotics: Should All Patients Take Them?

Authors:  Marta Katkowska; Katarzyna Garbacz; Aida Kusiak
Journal:  Microorganisms       Date:  2021-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.